SC Health Acquisition Corp (SC I) is a SPAC incorporated in the Cayman Islands in January 2025, focused on acquiring a company in the defense and aerospace sectors. SC I raised $253M in its May 2025 IPO, selling units at $10.00 each, with proceeds held in a trust that totaled approximately $259M as of December 31, 2025. The SPAC's sole purpose is to complete a Business Combination — acquiring a private company and taking it public — by November 2026, with extensions available to May 2027. The sponsor received Founder Shares at a nominal cost that convert to roughly 20% of the post-combination company, giving the sponsor upside if a deal closes and the combined company trades above $10.00. If no deal closes, public shareholders recover their pro rata trust value and the sponsor's shares become worthless. SC I is targeting mid-market defense and aerospace businesses — including corporate carve-outs from larger defense conglomerates — and expects to pursue targets with enterprise values exceeding the trust proceeds, requiring additional debt or equity financing to close. The two-person management team of CEO Menachem Shalom and CFO Asaf Yarkoni also run a second SPAC, SC II Acquisition Corp., which completed a $172.5M IPO in November 2025 and is also searching for a target, creating potential conflicts of interest.